![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CEP85L |
Gene summary for CEP85L |
![]() |
Gene information | Species | Human | Gene symbol | CEP85L | Gene ID | 387119 |
Gene name | centrosomal protein 85 like | |
Gene Alias | C6orf204 | |
Cytomap | 6q22.31 | |
Gene Type | protein-coding | GO ID | GO:0001764 | UniProtAcc | Q3ZCQ5 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
387119 | CEP85L | HTA11_3410_2000001011 | Human | Colorectum | AD | 7.29e-10 | 1.22e-01 | 0.0155 |
387119 | CEP85L | HTA11_2487_2000001011 | Human | Colorectum | SER | 3.19e-03 | 2.08e-01 | -0.1808 |
387119 | CEP85L | HTA11_1938_2000001011 | Human | Colorectum | AD | 1.15e-09 | 2.67e-01 | -0.0811 |
387119 | CEP85L | HTA11_347_2000001011 | Human | Colorectum | AD | 3.87e-04 | 9.01e-02 | -0.1954 |
387119 | CEP85L | HTA11_411_2000001011 | Human | Colorectum | SER | 3.74e-03 | 3.26e-01 | -0.2602 |
387119 | CEP85L | HTA11_2112_2000001011 | Human | Colorectum | SER | 8.61e-04 | 3.83e-01 | -0.2196 |
387119 | CEP85L | HTA11_3361_2000001011 | Human | Colorectum | AD | 2.96e-06 | 2.57e-01 | -0.1207 |
387119 | CEP85L | HTA11_83_2000001011 | Human | Colorectum | SER | 4.56e-04 | 1.76e-01 | -0.1526 |
387119 | CEP85L | HTA11_696_2000001011 | Human | Colorectum | AD | 4.00e-21 | 4.38e-01 | -0.1464 |
387119 | CEP85L | HTA11_1391_2000001011 | Human | Colorectum | AD | 7.29e-17 | 4.31e-01 | -0.059 |
387119 | CEP85L | HTA11_2992_2000001011 | Human | Colorectum | SER | 2.84e-06 | 3.14e-01 | -0.1706 |
387119 | CEP85L | HTA11_5212_2000001011 | Human | Colorectum | AD | 1.49e-02 | 1.73e-01 | -0.2061 |
387119 | CEP85L | HTA11_5216_2000001011 | Human | Colorectum | SER | 3.17e-08 | 4.73e-01 | -0.1462 |
387119 | CEP85L | HTA11_546_2000001011 | Human | Colorectum | AD | 4.57e-08 | 2.91e-01 | -0.0842 |
387119 | CEP85L | HTA11_6818_2000001011 | Human | Colorectum | AD | 1.69e-02 | 2.14e-01 | 0.0112 |
387119 | CEP85L | HTA11_6818_2000001021 | Human | Colorectum | AD | 6.86e-05 | 2.00e-01 | 0.0588 |
387119 | CEP85L | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.30e-03 | 9.85e-02 | 0.294 |
387119 | CEP85L | PTC04 | Human | Thyroid | PTC | 1.97e-02 | 6.04e-02 | 0.1927 |
387119 | CEP85L | PTC06 | Human | Thyroid | PTC | 3.76e-03 | 1.53e-01 | 0.2057 |
387119 | CEP85L | PTC07 | Human | Thyroid | PTC | 1.25e-05 | 1.07e-01 | 0.2044 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CEP85L | SNV | Missense_Mutation | c.76N>A | p.Gly26Arg | p.G26R | Q5SZL2 | protein_coding | tolerated_low_confidence(0.64) | benign(0) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD | |
CEP85L | SNV | Missense_Mutation | novel | c.605N>C | p.Ile202Thr | p.I202T | Q5SZL2 | protein_coding | tolerated(0.39) | benign(0.023) | TCGA-AX-A2HJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CEP85L | SNV | Missense_Mutation | rs199692317 | c.2348N>A | p.Arg783Gln | p.R783Q | Q5SZL2 | protein_coding | deleterious(0.01) | probably_damaging(0.997) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
CEP85L | SNV | Missense_Mutation | novel | c.2239N>A | p.Leu747Ile | p.L747I | Q5SZL2 | protein_coding | deleterious(0) | possibly_damaging(0.762) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
CEP85L | SNV | Missense_Mutation | novel | c.1532N>C | p.Ile511Thr | p.I511T | Q5SZL2 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CEP85L | SNV | Missense_Mutation | rs185836271 | c.1049N>A | p.Arg350His | p.R350H | Q5SZL2 | protein_coding | tolerated(0.32) | benign(0.003) | TCGA-BG-A0M4-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD |
CEP85L | SNV | Missense_Mutation | novel | c.1732G>A | p.Glu578Lys | p.E578K | Q5SZL2 | protein_coding | deleterious(0.01) | possibly_damaging(0.592) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CEP85L | SNV | Missense_Mutation | c.2147N>G | p.Asp716Gly | p.D716G | Q5SZL2 | protein_coding | tolerated(0.16) | probably_damaging(0.973) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
CEP85L | SNV | Missense_Mutation | c.1939C>T | p.Leu647Phe | p.L647F | Q5SZL2 | protein_coding | deleterious(0.01) | probably_damaging(0.956) | TCGA-D1-A17H-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
CEP85L | SNV | Missense_Mutation | novel | c.1997N>T | p.Arg666Ile | p.R666I | Q5SZL2 | protein_coding | tolerated(0.2) | benign(0.347) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |